| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.21 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |